Added to YB: 2021-07-20
Pitch date: 2021-07-20
AGTC [bullish]
Beacon Therapeutics (USA), Inc.
-90.16%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Beacon Therapeutics (USA), Inc., a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases.
Market Cap
$12.6M
Pitch Price
$4.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.28
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
APPLIED GENETIC TECHNOLOGIES AGTC
A summary for this pitch has not been created yet.
Read full article (0 min)